Core Viewpoint - Rongke Technology emphasizes its commitment to its core business of smart healthcare and aims to enhance its core business profitability to support long-term market value, despite the uncertainties in stock price influenced by various external factors [1]. Group 1 - As of the latest disclosed periodic report, the controlling shareholder, Henan Xinchuan Private Equity Investment Fund Partnership (Limited Partnership), holds 20.01% of the company's shares [1]. - The company's stock price is affected by multiple factors including macroeconomic environment, industry cycles, market sentiment, and capital flows, leading to uncertainty [1]. - The company has not received any plans from the controlling shareholder regarding share buybacks or increases in holdings [1]. Group 2 - The company will continue to focus on its main business of smart healthcare and aims to improve its core business profitability [1]. - The company commits to providing timely disclosures in accordance with legal and regulatory requirements if the controlling shareholder initiates any related actions in the future [1].

Core Viewpoint - The company, Rongke Technology, maintains stable operations in its core business, focusing on smart healthcare and smart services, and does not face the risk of becoming a shell company [1] Group 1: Company Performance - The company acknowledges that the overall medical information industry is experiencing operational pressures, which has led to short-term performance challenges due to industry environment and investments in product upgrades [1] - The company plans to concentrate on its core business, enhance technological innovation, expand market reach, and optimize management to improve profitability and protect shareholder interests [1] Group 2: Risk Assessment - As of now, the company does not face delisting risks, and stakeholders are advised to refer to officially disclosed information for the latest operational status [1]

Core Viewpoint - The news highlights that Rongke Technology clarified that the reported major asset restructuring project with Huatai United Securities is untrue, leading to a significant drop in its stock price by over 8% to 22.16 yuan per share [1] Company Summary - Rongke Technology confirmed through self-inspection and verification with relevant brokers that it has not engaged in any capital operations related to the reported restructuring [1] - The company emphasizes that all information should be based on announcements released through designated information disclosure media and advises investors to be cautious of rumors [1] - Rongke Technology's main business involves providing information solutions and services in areas such as smart healthcare, smart services, smart management, public healthcare services, and smart city services [1] - The actual controller of the company is the State-owned Assets Supervision and Administration Commission of the Henan Provincial People's Government [1] - The company stated on its investor interaction platform that the overall medical information industry is currently facing certain operational pressures [1] - Moving forward, Rongke Technology plans to focus on its core business, enhance technological innovation and market expansion efforts, optimize management, and strive to improve profitability while safeguarding the rights and interests of all shareholders [1]

Core Insights - The internet healthcare sector experienced a decline of 0.59% on October 16, with Rongke Technology leading the drop [1] - The Shanghai Composite Index closed at 3916.23, up 0.1%, while the Shenzhen Component Index closed at 13086.41, down 0.25% [1] Stock Performance - Notable gainers in the internet healthcare sector included: - Wanma Technology (300698) with a closing price of 50.09, up 10.94% and a trading volume of 237,000 shares, totaling 1.177 billion yuan [1] - Fengzhou Ziling (002424) at 5.95, up 9.98% with a volume of 482,600 shares, totaling 281 million yuan [1] - New Mileage (002219) at 2.45, up 9.87% with a volume of 3.4548 million shares, totaling 833 million yuan [1] - Decliners included: - Moke Technology (300290) at 22.16, down 8.54% with a volume of 435,700 shares, totaling 976 million yuan [2] - Zhongyuan Shares (300018) at 10.45, down 6.28% with a volume of 472,200 shares, totaling 500 million yuan [2] Capital Flow - The internet healthcare sector saw a net outflow of 702 million yuan from institutional investors, while retail investors contributed a net inflow of 343 million yuan [2][3] - Key stocks with significant capital flow included: - New Mileage (002219) with a net inflow of 1.59 billion yuan from institutional investors, but a net outflow from retail investors [3] - Wanma Technology (300698) with a net inflow of 146 million yuan from institutional investors [3]

Core Viewpoint - Rongke Technology's stock performance shows a slight increase, with significant financing activity indicating high investor interest despite a decline in revenue and profit [1][2]. Financing Activity - On October 15, Rongke Technology's stock rose by 0.71%, with a trading volume of 341 million yuan. The financing buy-in amounted to 35.46 million yuan, while financing repayment was 28.60 million yuan, resulting in a net financing buy of 6.85 million yuan [1]. - As of October 15, the total financing and securities lending balance for Rongke Technology reached 1.356 billion yuan, accounting for 8.75% of its market capitalization, which is above the 90th percentile of the past year [1]. - No shares were sold or repaid in the securities lending segment on October 15, with a balance of 0.00 yuan, indicating a high level of inactivity in this area [1]. Company Overview - Rongke Technology, established on November 18, 2005, and listed on February 16, 2012, is based in Shenyang, Liaoning Province. The company specializes in smart healthcare, health data, and intelligent cloud services [1]. - The revenue composition of Rongke Technology includes 73.25% from proprietary products and services, 26.64% from system integration, and 0.12% from other sources [1]. Financial Performance - For the first half of 2025, Rongke Technology reported a revenue of 292 million yuan, reflecting a year-on-year decrease of 7.01%. The net profit attributable to shareholders was -27.23 million yuan, a significant decline of 576.78% compared to the previous period [2]. - As of June 30, 2025, the number of shareholders decreased to 60,600, a reduction of 6.30%, while the average circulating shares per person increased by 6.76% to 10,556 shares [2]. - Since its A-share listing, Rongke Technology has distributed a total of 99.14 million yuan in dividends, with no dividends paid in the last three years [2].

Core Viewpoint - The company's stock price in the secondary market is influenced by various factors including macroeconomic environment, market sentiment, and industry expectations [2] Group 1: Company Performance - The company stated that its current performance is under short-term pressure due to industry adjustments and transformation investments [2] - The company emphasizes its commitment to strict information disclosure and denies any involvement in promoting speculative trading [2] Group 2: Strategic Focus - The company aims to focus on its core business and enhance profitability as a primary strategy [2] - The company plans to continuously disclose operational dynamics to guide the market's rational understanding of its value [2]

Core Viewpoint - Rongke Technology stated on October 15 that there have been no undisclosed changes in shareholding by current management or their relatives in the past six months [2] Summary by Categories - Company Disclosure - The company confirmed that there are no undisclosed shareholding changes by current management or their relatives in the last six months [2]

Core Viewpoint - Liu Bin, a senior executive of Rongke Technology, reduced his shareholding by 63,000 shares, representing 0.01% of the company's total shares, during the period from September 29, 2025, to October 10, 2025, while maintaining a total of 190,500 shares, which is 0.030% of the total share capital [1] Summary by Category - **Shareholding Reduction** - Liu Bin sold 63,000 shares through centralized bidding, accounting for 0.01% of the company's total shares [1] - After the reduction, Liu Bin holds 190,500 shares, which is 0.030% of the total share capital [1] - **Compliance and Impact** - The share reduction complies with relevant laws and regulations [1] - This action will not affect the company's control or ongoing operations [1]

关于高级管理人员减持计划实施完成的公告 证券代码：300290 证券简称：荣科科技 公告编号：2025-041 荣科科技股份有限公司 关于高级管理人员减持计划实施完成的公告 公司高管刘斌先生保证向本公司提供的信息内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 荣科科技股份有限公司（以下简称公司）于2025年9月5日在指定媒体巨潮资讯 网（http://www.cninfo.com.cn）披露了《高级管理人员减持股份预披露公告》，公司 高级管理人员刘斌计划自预披露公告发布之日起15个交易日后的3个月内拟通过集 中竞价交易方式减持不超过公司股份63,000股股份。具体事项详见公司于巨潮资讯 网披露的相关信息。 近日公司接到刘斌先生的通知，获悉其本次减持计划已实施完成。根据中国证 监会《上市公司股东、董监高减持股份的若干规定》、深圳证券交易所《创业板股 票上市规则》、《上市公司股东及董监高减持股份实施细则》等相关规定，现将刘 斌先生减持计划实施的情况公告如下： 2、本次股份变动前后上述股东的持股情况 | 股东名称 | 股份类型 | 本 ...

Core Viewpoint - Rongke Technology's stock has shown significant volatility, with a year-to-date increase of 36.76% but a recent decline of 11.54% over the past five trading days [1] Financial Performance - As of June 30, 2025, Rongke Technology reported a revenue of 292 million yuan, a year-on-year decrease of 7.01%, and a net profit attributable to shareholders of -27.23 million yuan, a decline of 576.78% [2] - The company has cumulatively distributed 99.14 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3] Stock Market Activity - On September 24, 2023, Rongke Technology's stock price reached 27.83 yuan per share, with a trading volume of 264 million yuan and a turnover rate of 1.52%, resulting in a total market capitalization of 17.804 billion yuan [1] - The stock has appeared on the "Dragon and Tiger List" once this year, with a net purchase of 141 million yuan on August 13, 2023 [1] Shareholder Information - As of June 30, 2025, the number of shareholders for Rongke Technology was 60,600, a decrease of 6.30% from the previous period, with an average of 10,556 shares held per shareholder, an increase of 6.76% [2] - The fourth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 2.0079 million shares, a decrease of 21,000 shares from the previous period [3] Business Overview - Rongke Technology, established on November 18, 2005, and listed on February 16, 2012, operates in smart healthcare, health data, and intelligent cloud services [1] - The company's main business revenue composition is 73.25% from self-developed products and services, 26.64% from system integration, and 0.12% from other sources [1][2]